Diazoxide may protect endothelial glycocalyx integrity during coronary artery bypass grafting

By Mennander Ari Adolf   Shalaby Ahmed   Oksala Niku   Leppänen Tiina   Hämäläinen Mari   Huovinen Sanna   Zhao Fang   Moilanen Eeva   Tarkka Matti  

Scandinavian Cardiovascular Journal, Vol. 46, Iss. 6, 2012-12 ,pp. : 339-344

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting

By Koster A.   Spiess B.   Chew D.P.   Krabatsch T.   Tambeur L.   DeAnda A.   Hetzer R.   Kuppe H.   Smedira N.G.   Lincoff A.M.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 356-359

Elsevier

Access to resources Recommend Favorite

Peripheral blood monocyte activation during coronary artery bypass grafting with or without cardiopulmonary bypass

By Wehlin Lena   Vedin Jenny   Vaage Jarle   Lundahl Joachim  

Scandinavian Cardiovascular Journal, Vol. 39, Iss. 1-2, 2005-04 ,pp. : 78-86

Informa Healthcare

Access to resources Recommend Favorite

Ventriculocoronary Revascularization: Is It as Effective as Coronary Artery Bypass Grafting?

By Scherer M.   Aybek T.   Abdel-Rahman U.   Dietrich M.   Moritz A.   Wimmer-Greinecker G.  

Cardiovascular Engineering: An International Journal, Vol. 5, Iss. 4, 2005-12 ,pp. : 151-156

Springer Publishing Company

Access to resources Recommend Favorite

Cause of death during 13 years after coronary artery bypass grafting with emphasis on cardiac death

By Herlitz Johan   Brandrup-Wognsen Gunnar   Caidahl Kenneth   Haglid-Evander Maria   Hartford Marianne   Karlson Björn   Karlsson Thomas   Sjöland Helén  

Scandinavian Cardiovascular Journal, Vol. 38, Iss. 5, 2004-10 ,pp. : 283-286

Informa Healthcare

Access to resources Recommend Favorite